Literature DB >> 1741774

Menadione-induced DNA damage in a human tumor cell line.

E O Ngo1, T P Sun, J Y Chang, C C Wang, K H Chi, A L Cheng, L M Nutter.   

Abstract

The nature and extent of menadione (MD)-induced DNA damage were explored using the human breast cancer cell line MCF-7. Concentration-dependent single-strand (ss) and double-strand (ds) DNA breaks were detected in MD-treated MCF-7 cells using the alkaline- and neutral-elution techniques, respectively. The repair of ss and ds DNA breaks was extensive but not complete after a 6-hr incubation in drug-free medium. Evidence was found for the production of DNA interstrand cross-links in MCF-7 cells treated with the bifunctional alkylating agent, mitomycin C, but not for cells treated with MD. Exposure of MCF-7 cells to etoposide (VP-16), mitoxantrone and camptothecin resulted in the detection of significant amounts of protein-linked DNA breaks, whereas none were found in MD-treated cells. These results support the proposition that MD-induced DNA damage is not likely to be mediated via topoisomerases, nor do significant amounts of protein-linked DNA form in MD-treated cells. Thus, MD serves as a good model for examination of the role of the quinone moiety in DNA damage in relation to redox cycling. Future studies directed at elucidation of the biochemical determinants mediating formation of reactive oxygen species effecting the MD-induced DNA damage are necessary and underway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741774     DOI: 10.1016/0006-2952(91)90596-w

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.

Authors:  Priya Srinivas; Chitta Ranjan Patra; Santanu Bhattacharya; Debabrata Mukhopadhyay
Journal:  Int J Nanomedicine       Date:  2011-09-23

2.  Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.

Authors:  A Halinska; T Belej; P J O'Brien
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 3.  Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds.

Authors:  Gang Chen; Feng Wang; Dunyaporn Trachootham; Peng Huang
Journal:  Mitochondrion       Date:  2010-08-14       Impact factor: 4.160

4.  The effect of pretreatment or combined treatment of quercetin on menadione toxicity in rat primary mixed glial cells in vitro.

Authors:  Pinar Oztopcu-Vatan; Selda Kabadere; Ruhi Uyar
Journal:  Cytotechnology       Date:  2009-10-31       Impact factor: 2.058

5.  Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells.

Authors:  Pinar Oztopcu-Vatan; Muge Sayitoglu; Melek Gunindi; Emine Inan
Journal:  Cytotechnology       Date:  2014-05-15       Impact factor: 2.058

6.  Critical role of oxidative stress in estrogen-induced carcinogenesis.

Authors:  Hari K Bhat; Gloria Calaf; Tom K Hei; Theresa Loya; Jaydutt V Vadgama
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

7.  Yeast apurinic/apyrimidinic endonuclease Apn1 protects mammalian neuronal cell line from oxidative stress.

Authors:  Renee Ho; Lyudmila I Rachek; Yi Xu; Mark R Kelley; Susan P LeDoux; Glenn L Wilson
Journal:  J Neurochem       Date:  2007-05-15       Impact factor: 5.372

Review 8.  Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis.

Authors:  Manuela Gago-Dominguez; Xuejuan Jiang; J Esteban Castelao
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  GC-FID and HPLC-DAD Methods for the Determination of Menadione Sodium Bisulphite Directly and by Converting Menadione Sodium Bisulphite to Menadione in Pharmaceutical Preparation.

Authors:  Fatma Demirkaya-Miloglu; Yucel Kadioglu; Onur Senol
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 10.  Vitamins and Melanoma.

Authors:  Irene Russo; Francesca Caroppo; Mauro Alaibac
Journal:  Cancers (Basel)       Date:  2015-07-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.